|
C20ORF72 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.959000E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.422200E-02 |
| Normal-vs-Stage2 |
3.484800E-01 |
| Normal-vs-Stage3 |
7.976600E-04 |
| Normal-vs-Stage4 |
9.69560000000369E-05 |
| Stage1-vs-Stage2 |
7.046000E-01 |
| Stage1-vs-Stage3 |
6.359800E-02 |
| Stage1-vs-Stage4 |
6.263800E-03 |
| Stage2-vs-Stage3 |
1.267050E-01 |
| Stage2-vs-Stage4 |
2.480100E-02 |
| Stage3-vs-Stage4 |
2.527000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.048800E-04 |
| Normal-vs-AfricanAmerican |
2.751700E-02 |
| Normal-vs-Asian |
2.312800E-01 |
| Caucasian-vs-AfricanAmerican |
9.480000E-01 |
| Caucasian-vs-Asian |
9.665000E-01 |
| AfricanAmerican-vs-Asian |
9.427600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.775100E-04 |
| Normal-vs-Female |
5.360900E-03 |
| Male-vs-Female |
4.132200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.519600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.776630E-04 |
| Normal-vs-Age(61-80Yrs) |
8.703100E-03 |
| Normal-vs-Age(81-100Yrs) |
3.025600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.451400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.615800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.877600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.759990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.603600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.544200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.787600E-02 |
| Normal-vs-Grade 2 |
1.146070E-02 |
| Normal-vs-Grade 3 |
1.180240E-03 |
| Normal-vs-Grade 4 |
3.792100E-04 |
| Grade 1-vs-Grade 2 |
7.358600E-01 |
| Grade 1-vs-Grade 3 |
9.130200E-01 |
| Grade 1-vs-Grade 4 |
5.416000E-01 |
| Grade 2-vs-Grade 3 |
4.742200E-01 |
| Grade 2-vs-Grade 4 |
4.179600E-02 |
| Grade 3-vs-Grade 4 |
1.312960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.811700E-02 |
| Normal-vs-ccB subtype |
1.795880E-03 |
| ccA subtype-vs-ccB subtype |
1.251410E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.171300E-04 |
| Normal-vs-N1 |
9.625000E-04 |
| N0-vs-N1 |
3.099800E-01 |
|
|
